Join thousands of biotech and life science leaders in our community
Welcome to
NewYorkBIO
Upcoming Events
The New York Stock Exchange
December 14, 2022 | 12:00 PM - 06:00 PM
NewYorkBIO has partnered with NYSE to bring together New York's financial community and emerging companies developing novel therapeutics in areas which could revolutionize patient care.
Latest News
Events
Join us Tuesday May 17th for another edition of our Virtual Breakfast Series featuring Dr.…
05/12/2022
Events
Join us Tuesday May 10th for another edition of our Virtual Breakfast Series featuring Dr.…
05/04/2022
Join us Tuesday May 3rd for another edition of our Virtual Breakfast Series featuring Luke…
04/28/2022
Join us Tuesday April 19th for another edition of our Virtual Breakfast Series featuring Mike…
04/14/2022
Join Thousands
Latest Jobs
Non-Profit | New York
NYSCF is seeking an Associate Scientist to join the Immunology team. This position reports directly to the Principal Scientist, Immunology, and works closely with…
Management | New York
LOCATION: New York, NY
REPORTS TO: CEO
SUMMARY: Oncology-experienced regulatory affairs specialist who will provide, develop and…
REPORTS TO: CEO
SUMMARY: Oncology-experienced regulatory affairs specialist who will provide, develop and…
| New York
Involvement in all aspects of clinical trial design and execution, including authoring protocols, medical content and leadership of the clinical studies, with…
StatNews 11/22/2022
The FDA approved the first gene therapy to treat people with hemophilia B, an inherited bleeding ...
11/22/2022
British pharma giant GSK said Tuesday that it will withdraw its blood cancer drug Blenrep from the ...
11/21/2022
Northwest Biotherapeutics tried again, but its experimental treatment for brain cancer still falls ...
11/21/2022
Merck said Monday that it is acquiring Imago BioSciences for $1.35 billion, adding experimental ...
11/21/2022
The unprecedented success of mRNA vaccines against Covid is raising hopes that the technology could ...
11/18/2022
Biosplice announced that its experimental osteoarthritis drug failed to benefit patients in a pair ...
11/18/2022
It might seem far-fetched, but self-replicating mRNA drugs that come with a built-in "copy machine" ...
11/17/2022
Editas Medicine, one of the small handful of original CRISPR companies, announced it is halting ...
11/17/2022
Vertex executives laid out an ambitious vision in which the company is taking aim at everything ...